DE60303040D1 - Dihydro-dibenzo[b,e]oxepin-basierte, selektive oestrogen-rezeptor modulatoren, zusammensetzungen und methoden - Google Patents
Dihydro-dibenzo[b,e]oxepin-basierte, selektive oestrogen-rezeptor modulatoren, zusammensetzungen und methodenInfo
- Publication number
- DE60303040D1 DE60303040D1 DE60303040T DE60303040T DE60303040D1 DE 60303040 D1 DE60303040 D1 DE 60303040D1 DE 60303040 T DE60303040 T DE 60303040T DE 60303040 T DE60303040 T DE 60303040T DE 60303040 D1 DE60303040 D1 DE 60303040D1
- Authority
- DE
- Germany
- Prior art keywords
- sub
- sup
- alkyl
- methods
- oxepin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/12—[b,e]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Resins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39853802P | 2002-07-24 | 2002-07-24 | |
US398538P | 2002-07-24 | ||
PCT/US2003/019554 WO2004009603A1 (en) | 2002-07-24 | 2003-07-11 | Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60303040D1 true DE60303040D1 (de) | 2006-02-02 |
DE60303040T2 DE60303040T2 (de) | 2006-08-03 |
Family
ID=30771225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60303040T Expired - Fee Related DE60303040T2 (de) | 2002-07-24 | 2003-07-11 | Dihydro-dibenzo[b,e]oxepin-basierte, selektive oestrogen-rezeptor modulatoren, zusammensetzungen und methoden |
Country Status (8)
Country | Link |
---|---|
US (2) | US7067510B2 (de) |
EP (1) | EP1527076B1 (de) |
JP (1) | JP2005538091A (de) |
AT (1) | ATE314375T1 (de) |
AU (1) | AU2003281632A1 (de) |
DE (1) | DE60303040T2 (de) |
ES (1) | ES2253691T3 (de) |
WO (1) | WO2004009603A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007098086A2 (en) * | 2006-02-17 | 2007-08-30 | Avalon Pharmaceuticals | Hydroxypiperidine derivatives and uses thereof |
JP2010527915A (ja) * | 2007-04-26 | 2010-08-19 | アバロン ファーマシューティカルズ,インコーポレイテッド | 多重環化合物及びその用途 |
AU2016366680B2 (en) | 2015-12-09 | 2021-06-24 | The Board Of Trustees Of The University Of Illinois | Benzothiophene-based selective estrogen receptor downregulators |
CN110177554B (zh) | 2017-01-06 | 2023-06-02 | G1治疗公司 | 用于治疗癌症的组合疗法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391892B1 (en) * | 1995-03-10 | 2002-05-21 | Eli Lilly And Company | Naphthyl pharmaceutical compounds |
US5726186A (en) | 1995-09-08 | 1998-03-10 | Eli Lilly And Company | Pentacyclic compounds, intermediates, processes, compositions, and methods |
IL138084A0 (en) | 1998-03-02 | 2001-10-31 | Lilly Co Eli | Fluoxetine hydrochloride for decreasing hot flashes |
US6471979B2 (en) * | 1999-12-29 | 2002-10-29 | Estrogen Vascular Technology, Llc | Apparatus and method for delivering compounds to a living organism |
-
2003
- 2003-07-11 DE DE60303040T patent/DE60303040T2/de not_active Expired - Fee Related
- 2003-07-11 US US10/521,137 patent/US7067510B2/en not_active Expired - Fee Related
- 2003-07-11 AT AT03742113T patent/ATE314375T1/de not_active IP Right Cessation
- 2003-07-11 JP JP2004523010A patent/JP2005538091A/ja not_active Withdrawn
- 2003-07-11 AU AU2003281632A patent/AU2003281632A1/en not_active Abandoned
- 2003-07-11 ES ES03742113T patent/ES2253691T3/es not_active Expired - Lifetime
- 2003-07-11 EP EP03742113A patent/EP1527076B1/de not_active Expired - Lifetime
- 2003-07-11 WO PCT/US2003/019554 patent/WO2004009603A1/en active IP Right Grant
-
2006
- 2006-02-17 US US11/276,203 patent/US7375229B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE314375T1 (de) | 2006-01-15 |
EP1527076A1 (de) | 2005-05-04 |
ES2253691T3 (es) | 2006-06-01 |
US20050240017A1 (en) | 2005-10-27 |
AU2003281632A1 (en) | 2004-02-09 |
US7375229B2 (en) | 2008-05-20 |
EP1527076B1 (de) | 2005-12-28 |
DE60303040T2 (de) | 2006-08-03 |
US7067510B2 (en) | 2006-06-27 |
JP2005538091A (ja) | 2005-12-15 |
US20060142267A1 (en) | 2006-06-29 |
WO2004009603A1 (en) | 2004-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ294177A (en) | 1-aralkyl-, 2-aryl-substituted naphthyl derivatives and pharmaceutical formulations | |
HUP0000901A2 (hu) | 16-Hidroxi-11-(szubsztituált fenil)ösztra-4,9-dién-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
NO20062032L (no) | Derivater av N-[fenyl(pyrrolidin-2-yl)-metyl]benzamid og N-[(azepan-2-yl)fenylmetyl]benzamid, fremgangsmate for fremstilling derav og anvendelse derav i terapeutiske midler | |
UY27384A1 (es) | Analogos de prostaglandina | |
CA2632567A1 (en) | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors | |
HUP0301422A2 (hu) | Ösztrogén hatású szereket tartalmazó gyógyászati készítmények | |
DE69628246D1 (de) | Naphthyl- und Dihydronaphthylverbindungen als Arzneimittel | |
JP2005531488A5 (de) | ||
KR960701878A (ko) | 수용성 캄프토테신 유도체, 이의 제조 방법 및 항종양제로서의 이의 용도(Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents) | |
DE69532079D1 (de) | Benzofuranverbindungen, präparate und verfahren | |
DE60303040D1 (de) | Dihydro-dibenzo[b,e]oxepin-basierte, selektive oestrogen-rezeptor modulatoren, zusammensetzungen und methoden | |
NO975581L (no) | Fremgangsmåte for å redusere bentap | |
KR970705999A (ko) | 타목시펜 및 타목시펜 유사체의 자궁향성 효과를 최소화시키는 방법 (a method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs) | |
AU2003247589A8 (en) | Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them | |
MXPA05003166A (es) | Derivados de dihidro-dibenzo (a) antracenos y su uso como modulares de receptores de estrogenos selectivos. | |
HUP0200913A2 (hu) | Izoindoloindolonszármazékok eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
JP2005538091A5 (de) | ||
JP2004531559A5 (de) | ||
DE60031557D1 (de) | Steroide, ihre herstellung , pharmazeutische zusammensetzungen mit ihnen und verwendungen dieser verbindungen | |
YU34296A (en) | Use a compounds for medicament obtaining and pharmaceutical composition thereof | |
HUP0002715A2 (hu) | Benzotiofénszármazékok alkalmazása trombocitaszám csökkentésére szolgáló gyógyszerkészítmények előállítására | |
HUP0004994A2 (hu) | 2,3-Benzodiazepin-származékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk | |
RS49886B (sr) | Benzotiofenska jedinjenja, intermedijari, kompozicije i metode |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |